Global
autoimmune disease diagnostics market is expected to reach USD 14.17 billion by
2020. Growing prevalence of autoimmune diseases coupled with the presence of
favorable government initiatives such as the Affordable Care Act is expected to
positively reinforce the autoimmune disease diagnostics market. Slow turnaround
duration and presence of fewer diagnostic tests catering to nearly 80 disease
types and the consequent rise in lab automation rates are expected to drive
market growth during the forecast period. Automation of laboratories is
expected enable clinicians with the ability to conduct several diagnostic tests
simultaneously and generate accurate and rapid results. Technological advances
such as the development of novel biomarkers and portable diagnostic point of
care equipment are further expected to boost procedure volumes.
Systemic
autoimmune disease diagnostics is the most lucrative segment of this market.
Presence of high unmet patient needs in disease segments such as rheumatoid
arthritis and systemic lupus E. coupled with the introduction of new products
for example Avise SLE marker for lupus diagnosis are some factors expected to
drive segment growth over the next six years. In addition, implementation of
initiatives aimed at developing effective diagnostic and therapeutic solutions
for systemic diseases with high prevalence for instance rheumatoid arthritis is
further expected to drive segment growth.
View Full Report with TOC @ http://www.radiantinsights.com/research/autoimmune-disease-diagnostics-market-analysis-by-product-systemic-localized-rheumatoid-arthritis-systemic-lupus-erythematosus-ankylosing-spondylitis-and-segment-forecasts-to-2020
Further key findings from the study
suggest:
Rheumatoid
arthritis emerged as the fastest growing product segment. Its market is
expected to grow at a CAGR of over 4.0% from 2014 to 2020. High prevalence of
rheumatoid arthritis and the involvement of expensive assessment tests are few
factors attributing to its rapid growth.
Localized
autoimmune disease diagnostics was the leading product segment of this market
in 2013. Extensive presence of commercialized diagnostic products and growing
prevalence of gastrointestinal autoimmune disorders are some factors accounting
for its large share.
North
America was the largest regional market in 2013, accounting for a share of over
40.0%. Its large share is attributed by the introduction of the Affordable Care
Act, presence of favorable initiatives undertaken by the AARDA and high disease
prevalence levels in the region.
Asia
Pacific is expected to witness promising growth over the next six years.
Constantly improving healthcare infrastructure and patient awareness levels in
the emerging markets of India and China have now opened up new avenues for the
manufacturers to capitalize on.
Download sample Copy of This Report at: http://www.radiantinsights.com/research/autoimmune-disease-diagnostics-market-analysis-by-product-systemic-localized-rheumatoid-arthritis-systemic-lupus-erythematosus-ankylosing-spondylitis-and-segment-forecasts-to-2020#tabs-4
Some
key players of the autoimmune disease diagnostics market include Abbott
Laboratories, Quest Diagnostics, Siemens Healthcare, Beckman Coulter Inc. and
SQI Diagnostics.
Introduction
of technologically innovative products such as Celiac panel tests enabling
faster IgG & IgA antibodies detection is one of the major sustainability
strategies adopted by the market players
Table of Contents
Chapter
1 Executive Summary
Chapter
2 Autoimmune Disease Diagnostics Industry Outlook
2.1 Market Segmentation
2.2 Market Size and Growth
Prospects
2.3 Autoimmune disease
diagnostics - Market dynamics
2.3.1 Market Driver Analysis
See More Reports of This Category
by Radiant Insights:
·
India Respiratory Disposables Market Outlook to 2021
- http://www.radiantinsights.com/research/india-respiratory-disposables-market-outlook-to-2021
·
India Respiratory Measurement Devices Market Outlook
to 2021 - http://www.radiantinsights.com/research/india-respiratory-measurement-devices-market-outlook-to-2021
2.3.1.2 Presence of research
funding programs
2.3.1.3 Presence of favorable
government initiatives
2.3.1.4 Growing patient awareness
levels
2.3.1.5 Technological innovation
in the form of lab automation
2.3.2 Market Restraint Analysis
2.3.2.1 Slow diagnostic result
turnaround times and lack of skilled healthcare practitioners
2.4 Key Opportunities
Prioritized
2.5 Industry Analysis - Porter's
2.6 Autoimmune Disease
Diagnostics - PESTEL Analysis
About Radiant Insights
Radiant
Insights is a platform for companies looking to meet their market research and
business intelligence requirements. We assist and facilitate organizations and
individuals procure market research reports, helping them in the decision making
process. We have a comprehensive collection of reports, covering over 40 key
industries and a host of micro markets. In addition to over extensive database
of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
For More Information, Visit Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog URL: http://www.radiantinsightsinc.blogspot.com
No comments:
Post a Comment